Press Releases April 30, 2026 07:00 AM

GigaCloud Technology Inc to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026

GigaCloud Technology to Release Q1 2026 Financials and Host Earnings Call on May 7, 2026

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
GCT

GigaCloud Technology Inc, a Nasdaq-listed company specializing in global B2B ecommerce platforms for large parcel merchandise, announced it will report its first quarter 2026 financial results on May 7, 2026, followed by a conference call to discuss these results. The company’s platform connects manufacturers, mainly in Asia, with resellers worldwide, offering integrated discovery, payment, and logistics solutions.

GigaCloud Technology Inc to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
GCT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • GigaCloud will release Q1 2026 financial results before market open on May 7, 2026.
  • The company operates a global B2B ecommerce platform connecting Asian manufacturers with resellers in multiple regions.
  • The platform integrates product discovery, payments, and logistics, supporting cross-border large parcel merchandise transactions at fixed prices.

EL MONTE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that it will report financial results for the 2026 first quarter ended March 31, 2026 before the market opens on Thursday, May 7, 2026. The Company will host a conference call to discuss its financial results on the same day at 8:00 AM Eastern Time.

To access the conference call, participants should pre-register here to receive the dial-in information and a unique PIN. All participants are encouraged to dial-in 15 minutes prior to the conference call’s start time. 

A live and archived webcast of the conference call will be accessible on the Company’s investor relations website at https://investors.gigacloudtech.com/news-events/events.

About GigaCloud Technology Inc
GigaCloud Technology Inc is a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise. The Company’s B2B ecommerce platform, which it refers to as the “GigaCloud Marketplace,” integrates everything from discovery, payments and logistics tools into one easy-to-use platform. The Company’s global marketplace seamlessly connects manufacturers, primarily in Asia, with resellers, primarily in the U.S., Asia and Europe, to execute cross-border transactions with confidence, speed and efficiency. The Company offers a truly comprehensive solution that transports products from the manufacturer’s warehouse to the end customer’s doorstep, all at one fixed price. The Company first launched its marketplace in January 2019 by focusing on the global furniture market and has since expanded into additional categories such as home appliances and fitness equipment. For more information, please visit the Company’s website: https://investors.gigacloudtech.com/.

For investor and media inquiries, please contact:

GigaCloud Technology Inc.
ir@gigacloudtech.com

Pondel Wilkinson Inc.
Laurie Berman (Investors)                Todd Kehrli (Investors)                        
Lberman@pondel.com                     Tkehrli@pondel.com

George Medici (Media)
gmedici@pondel.com


Risks

  • Financial results may not meet market expectations, potentially impacting stock price and investor confidence.
  • Expansion into new product categories may expose the company to operational challenges or increased competition.
  • Dependence on cross-border trade and global logistics can pose risks amid geopolitical or supply chain disruptions.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026